US stock market anomaly | Amgen (AMGN.US) rose by 6% with third-quarter sales exceeding expectations and raising full-year performance guidance.

According to the Wise Financial APP, on Wednesday, Amgen (AMGN.US) rose by 6% to $314.58. On the news front, Amgen's third-quarter revenue increased by 12% year-on-year to $9.56 billion, higher than analysts' expectations of $8.97 billion; adjusted earnings per share were $5.64, also higher than the expected $5.01. The company raised its full-year performance guidance, expecting revenue to be between $35.8 billion and $36.6 billion, and earnings per share to be between $20.6 and $21.4.